IRS Issues Final Rule Implementing Medical Device Excise Tax

The Internal Revenue Service released a

implementing a Patient Protection and Affordable Care Act provision that imposes on certain medical devices made after 2012 an excise tax equal to 2.3% of their sales price. In submitted on the proposed rule AHRMM, the American Hospital Association and others urged the IRS to explicitly prohibit device companies from passing the tax on to customers, and to clarify that hospitals and other healthcare providers who package and sterilize devices for use in surgery kits should not be treated as device manufacturers or importers under the rule. The final rule does not address AHRMM’s recommendation that manufacturers certify that the tax has not been passed on to customers, but provides that current rules apply in determining the sales price of items. Also, of importance, the final rule states that a kit produced by a hospital or medical institution for its own use would not be a taxable medical device.

Related Resources

Podcasts
Get the basics on what healthcare supply chain and manufacturers, together with clinical and IT departments, must do to implement the Unique Device
Webcast
Brent Petty, executive industry consultant, Healthcare Lexmark International, discusses what forces are currently affecting health care and the pla
On-Demand Educational Webinars
This webinar discusses the health care supply chain, its strengths and weaknesses. It reviews best practices around the industry, including what…
Podcasts
Hear one provider’s ongoing process of UDI implementation, from deciphering acronyms and educating interdepartmental staff, to working with vendors